Concepedia

Author

Issa F. Khouri

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

I F Khouri, I Khouri, I. F. Khouri, I. Khouri, I.F. Khouri, Issa F Khouri, Issa F. Khouri, Issa Khouri, Issa F. Khouri, Issa F. Khouri

600

Publications

19.9K

Citations

74

H-Index

69

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterLymphoma Research Foundation
IF

About

Issa F. Khouri is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

39

69

3.9K

2

Health Sciences

24

28

1.4K

3

Language Studies

1

1

15

4

Public Health

1

1

24

5

Biomedical Engineering

1

1

263

Issa F. Khouri

×

211

Publications

18.4K

Citations

72

H-Index

YearCitations

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu H. Estey, Maher Albitar,

Blood

1997

1.2K

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling,

Journal of Clinical Oncology

1998

927

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri,

Blood

2001

570

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri,

Blood

2001

516

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Issa F. Khouri, Rima M. Saliba, Sergio Giralt,

Blood

2001

363

Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience

Yasuhiro Oki, Mansoor Noorani, Pei Lin,

British Journal of Haematology

2014

361

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

Issa F. Khouri, Jorge Romaguera, Hagop M. Kantarjian,

Journal of Clinical Oncology

1998

358

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

Sergio Giralt, J. P. Hester, Yang O. Huh,

Blood

1995

330

Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

Apostolia M. Tsimberidou, Susan O’Brien, Issa F. Khouri,

Journal of Clinical Oncology

2006

297

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Issa F. Khouri, Peter McLaughlin, Rima M. Saliba,

Blood

2008

293

Page 1